https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accounts-payable https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accounts-payable-other-current-and-noncurrent https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accounts-receivable https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accretion-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accrued-liabilities https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accumulated-depreciation https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/acquired-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability-1 https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/acquisitions https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/additional-paid-in-capital https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/adjustment-for-amortization https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/amended-reports-10-k https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/amended-reports-10-q https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/amortization https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/basic-earnings-per-share-adjustment-pro-forma https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/basic-shares https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisition-contingent-consideration-at-fair-value https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisition-cost-of-acquired-entity-purchase-price https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisition-equity-interest-issued-or-issuable-value-assigned https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisition-purchase-price-allocation-current-assets-inventory https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisition-purchase-price-allocation-current-liabilities https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisition-purchase-price-allocation-goodwill-amount https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisition-purchase-price-allocation-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/capital-expenditures https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cash https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cash-and-equivalents https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cash-flow-breakdown https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/common-stock-value https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/comprehensive-income https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/concentration-risk-credit-risk-financial-instrument-maximum-exposure https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/concentration-risk-percentage https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/convertible-debt https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cost-of-goods-sold https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cost-of-goods-sold-amortization https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cost-of-real-estate-sales https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cost-of-revenue https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cost-of-revenue-2 https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/credit-risk-derivative-assets-at-fair-value https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/cumulative-earnings-deficit https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/current-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/current-liabilities https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/customer-refund-liability-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-annual-principal-payment https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-issuance-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-issued https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-periodic-payment-interest https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-related-commitment-fees-and-debt-issuance-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/debt-repaid https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-finance-costs-current-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-finance-costs-ownshare-lending-arrangement-issuance-costs-adjustment https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-revenue https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/deposit-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/depreciation-nonproduction https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/derivative-liabilities https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/derivative-liabilities-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/diluted-shares https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/dilutive-shares https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/employee-stock-ownership-plan-esop-compensation-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/entity-wide-revenue-major-customer-percentage https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/eps https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/eps-basic https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/expense-related-to-distribution-or-servicing-and-underwriting-fees https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-gain-loss-included-in-earnings https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-issues https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-purchases-sales-issues-settlements https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-sales https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/fair-value-net-derivative-asset-liability-with-unobservable-inputs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/financing-cash-flow https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/finite-lived-patents-gross https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/foreign-currency-transaction-loss-before-tax https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/form-d-other https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/form-d-stocks https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/gain-loss-on-foreign-currency-fair-value-hedge-derivatives https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/geographic-revenue-from-external-customers-attributed-to-entitys-country-of-domicile https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/geographic-revenue-from-external-customers-attributed-to-foreign-countries https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/goodwill https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/goodwill-acquired https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/goodwill-gross https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/gross-profit https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/income-loss-from https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/income-taxes-paid https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-fair-value-of-unhedged-derivative-instruments https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-intangible-assets-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/indefinite-lived-license-agreements https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/insider-transactions-warrants https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/interest-and-debt-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/interest-and-other-income https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/interest-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/interest-expense-other https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/interest-paid https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/interest-receivable https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/inventory https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/inventory-write-down https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/investing-cash-flow https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/lease-and-rental-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/legal-fees https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/license-and-maintenance-revenue https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/license-and-services-revenue https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/license-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/licenses-revenue https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/loans-and-leases-receivable-other https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/maximum-potential-future-exposure-on-credit-risk-derivatives https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/net-change-in-cash https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/net-income https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/non-hedging-derivatives-gain-loss-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/noncash-or-part-noncash-acquisition-payables-assumed https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/oci-unrealized-gain-loss-on-derivatives-arising-net-of-tax https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-cash-flow https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-expenses https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-income https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-lease-payments-due https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-lease-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-lease-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-leases-future-minimum-payments-next-rolling-twelve-months https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-current-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-current-liabilities https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-long-term-debt-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-long-term-debt-noncurrent https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-noncash-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-noncurrent-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-restructuring-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-sales-revenue-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/other-short-term-borrowings https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/paid-in-capital-share-based-compensation-other-longterm-incentive-plans-requisite-service-period-recognition https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/payments-for-commissions https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/payments-for-fees https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/payments-of-financing-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/pension-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/prepaid-expense-current https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/pretax-income-domestic https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/pro-forma-weighted-average-shares-outstanding-diluted https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/product-warranty-accrual-preexisting-increase-decrease https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/property-plant-equipment https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/public-float https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/purchase-obligation https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/purchase-obligation-due-in-fourth-year https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/purchase-obligation-due-in-second-year https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/purchase-obligation-due-in-third-year https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/purchase-obligation-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/research-and-development https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/restructuring-costs https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/retail-related-inventory-packaging-and-other-supplies https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/retained-earnings https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/revenue https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/royalty-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/royalty-revenue https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sales-returns-and-allowances-goods https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sales-revenue-net https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-10-k https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-10-q https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-10ksb https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-10qsb https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-10sb12g https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-15-12g https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-425 https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-8-k https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-ct-order https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-def-14a https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sec-filings-ntn-10k https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/secondary-offerings-form-f-3 https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/sga-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/shareholders-equity https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/shares-authorized https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/shares-issued https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/short-term-debt https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-based-compensation https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-issued-shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-outstanding-change-average-exercise-price https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/tax-reconciliation-equity-in-earnings-losses-of-unconsolidated-subsidiary https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/total-assets https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/total-liabilities https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/total-long-term-debt https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/tribute-pharmaceuticals-canada-inc/weighted-average-number-of-share-outstanding-basic-and-diluted